Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05117242 |
|---|---|
| Brief Title: | Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer |
| First Submitted : | November 1, 2021 |
| First Submitted that Met QC Criteria : | November 10, 2021 |
| First Posted : | November 11, 2021 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 3, 2024 |